Primary Sjogren's syndrome in the North East of England: A long-term follow-up study

Rheumatology

Volumn 38, Issue 3, 1999, Pages 245-253

  Davidson, B K S ^b   Kelly, C A ^a   Griffiths, I D ^b  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Autoantibody; HLA; Lymphoma; Sjogren's syndrome

Indexed keywords

AUTOANTIBODY; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; ANTINUCLEAR ANTIBODY; SS A ANTIBODIES; SS-A ANTIBODIES;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; NONHODGKIN LYMPHOMA; PAROTID GLAND; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED KINGDOM; DISEASE COURSE; IMMUNOLOGY; LYMPHATIC SYSTEM DISEASE; LYMPHOMA; MIDDLE AGED; MORTALITY; SEROLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DISEASE PROGRESSION; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC DISEASES; LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; SEROLOGIC TESTS; SJOGREN'S SYNDROME;

EID: 0033087683     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.3.245     Document Type: Article

References (44)

1. Kruize AA, Hene RJ, van der Heide A, Bodeutsch C, de Wilde PC, van Bijsterveld OP et al. Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum 1996;39:297-303.
2. Mialon P, Barthelemy L, Sebert P, Le Henaff C, Sarni D, Pennec YL et al. A longitudinal sludy of lung impairment in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1997;15:349-54.
3. Franquet T, Gimenez A, Monill JM, Diaz C, Geli C. Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. Am J Roentgenol 1997;169:655-8.
4. Shiozawa S, Shiozawa K, Shimizu S, Nakada M, Isobe T, Fujita T. Clinical studies of renal disease in Sjögren's syndrome. Ann Rheum Dis 1987;46:768-72.
5. Moutsopoulos HM, Sarmas JH, Talal N. Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am 1993;19:909-12.
6. Hietaharju A, Jantti V, Korpela M, Frey H. Nervous system involvement in systemic lupus erythematosus, Sjögren syndrome and scleroderma. Acta Neurol Scand 1993;88:299-308.
7. Alexander E. Central nervous system disease in Sjögren's syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am 1992;18:637-72.
8. Tishler M, Alosachie I, Barka N. Lin HC, Gershwin ME, Peter JB et al. Primary Sjögren's syndrome and primary biliary cirrhosis: differences and similarities in the autoantibody profile. Clin Exp Rheumatol 1995;13:497-500.
9. Czirjak L, Zeher M, Nagy Z, Szegedi G. Sjögren's syndrome, primary biliary cirrhosis and overlap with scleroderma symptoms. J Intern Med 1993;233:427-8.
10. Uddenfeldt P, Danielsson A, Forssell A, Holm M, Ostberg Y. Features of Sjögren's syndrome in patients with primary biliary cirrhosis. J Intern Med 1991;230:443-8.
11. Tsianos EV, Hoofnagle JH, Fox PC, Alspaugh M, Jones EA, Schafer DF et al. Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology 1990;11:730-4.
12. Scofield RH. Autoimmune thyroid disease in systemic lupus erythematosus and Sjögren's syndrome. Clin Exp Rheumatol 1996;14:321-30.
13. Loviselli A, Mathieu A, Pala R, Mariotti S, Cau S, Marongiu C et al. Development of thyroid disease in patients with primary and secondary Sjögren's syndrome. J Endocrinol Invest 1988;11:653-6.
14. Foster H, Fay A, Kelly C, Charles P, Walker D, Griffiths I. Thyroid disease and other autoimmune phenomena in a family study of primary Sjögren's syndrome. Br J Rheumatol 1993;32:36-40.
15. Bell DA. SLE in the elderly - is it really SLE or systemic Sjögren's syndrome? J Rheumatol 1988;15:723-4.
16. Rasker JJ, Jayson MI, Jones DE, Matthews R, Burton JL, Rhys Davies E et al. Sjögren's syndrome in systemic sclerosis. A clinical study of 26 patients. Scand J Rheumatol 1990;19:57-65.
17. Gharavi AE, Skopouli FN, Patel BM, Hughes GR, Moutsopoulos HM. Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patients. Rheumatol Int 1986;6:61-2.
18. Moutsopoulos HM, Skopouli FN, Sarras AK, Tsampoulas C, Mavridis AK, Constantopoulos SH et al. Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects. Ann Rheum Dis 1985;44:215-9.
19. Zufferey P, Meyer OC, Grossin M, Kahn MF. Primary Sjögren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol 1995;24:342-5.
20. Stewart A, Blenkinsopp PT, Henry K. Bilateral parotid MALT lymphoma and Sjögren's syndrome. Br J Oral Maxillofac Surg 1994;32:318-22.
21. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
22. Kelly CA, Foster H, Pal B, Gardiner P, Malcolm AJ, Charles P et al. Primary Sjögren's syndrome in north east England a longitudinal study. Br J Rheumatol 1991;30:437-42.
23. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren's syndrome. Proposed criteria for classification. Arthritis Rheum 1986;29:577-85.
24. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
25. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Ann Rheum Dis 1996;55:116-21.
26. Venables PJW, Charles PJ, Buchanan RRC. Quantitation and detection of isotypes of anti-SS-B antibodies by ELISA and Farr assay using purified antigens. Arthritis Rheum 1983;26:146-55.
27. Dewar PJ. The role of the laboratory in rheumatology. HLA antigens. Clin Rheum Dis 1983;9:93-116.
28. Hay E, Chambers H, Thomas E, Hajeer A, Silman A. Lack of association between subjective symptoms and objective testing of dry eyes and dry mouth: results from population based study. Br J Rheumatol 1997;36(supp. 1):26.
29. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on Diagnostic Criteria For Sjögren's Syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994;53:637-47.
30. Wener MH, Johnson RJ, Sasso EH, Gretch DR. Hepatitis C virus and rheumatic disease. J Rheumatol 1996;23:953-9.
31. Coll J, Gambus G, Corominas J, Tomas S, Esteban JI, Guardia J. Immunohistochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus infection. Ann Rheum Dis 1997;56:390-2.
32. Vitali C, Sciuto M, Neri R, Greco F, Mavridis AK, Tsioufas AG et al. Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gamma-globulinaemia. Clin Exp Rheumatol 1992;10:103-4.
33. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ et al. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997;15:361-5.
34. Coll J, Anglada J, Tomas S, Reth P, Goday A, Millan M et al. High prevalence of subclinical Sjögren's syndrome features in patients with autoimmune thyroid disease. J Rheumatol 1997;24:1719-24.
35. Krejsek J, Slezak R, Kopecky O, Derner V, Andrys C. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome. Clin Rheumatol 1997;16:149-53.
36. Raum D, Awdeh Z, Yunis EJ, Alper CA, Gabbay KH. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest 1984;74:449-54.
37. Alper CA, Fleischnick E, Awdeh Z, Katz AJ, Yunis EJ. Extended major histocompatibility complex haplotypes in patients with gluten-sensitive enteropathy. J Clin Invest 1987;79:251-6.
38. Bishof NA, Welch TR, Beischel LS, Carson D, Donnelly PA. DP polymorphism in HLA-A1, -B8, -DR3 extended haplotypes associated with membranoproliferative glomerulonephritis and systemic lupus erythematosus. Pediatr Nephrol 1993;7:243-6.
39. Ricchiuti V, Isenberg D, Muller S. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome. J Autoimmun 1994;7:611-21.
40. Foster H, Stephenson A, Walker D, Cavanagh G, Kelly C, Griffiths I. Linkage studies of HLA and primary Sjögren's syndrome in multicase families. Arthritis Rheum 1993;36:473-84.
41. Papasteriades CA, Skopouli FN, Drosos AA, Andonopoulos AP, Moutsopoulos HM. HLA-alloantigen associations in Greek patients with Sjögren's syndrome. J Autoimmun 1988;1:85-90.
42. Whittingham S, Mackay IR, Tait BD. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome. Aust NZ J Med 1983;13:565-70.
43. Fye KH, Terasaki PI, Michalski JP, Daniels TE, Opelz G, Talal N. Relationship of HLA-Dw3 and HLA-B8 to Sjögren's syndrome. Arthritis Rheum 1978;21:337-42.
44. Valesini G, Priori R, Bavoillot D, Osborn J, Danieli MG, DelPapa N et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol 1997;24:2376-80.